- Expert panel to provide proactive, evidence-informed recommendations that are costed and implementable -
A panel of 17 leading experts in dementia care
A drug that offers a small benefit to Alzheimer's patients is making a big splash with doctors who treat the disease.The drug, a monoclonal antibody called lecanemab, dominated last week's Cli
Encore: Is lecanemab the Alzheimer s drug that will finally make a difference? wnmufm.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wnmufm.org Daily Mail and Mail on Sunday newspapers.